Anzeige
Mehr »
Login
Sonntag, 30.03.2025 Börsentäglich über 12.000 News von 696 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Edison Investment Research-Archiv vom 07.03.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
07.03.OSE Immunotherapeutics - KOL event highlights lusvertikimab's potential258OSE Immunotherapeutics and Edison held a key opinion leader (KOL) event on 5 March 2025, providing up-to-date insights into OSE's lead immuno-inflammation candidate, lusvertikimab, following the European...
► Artikel lesen
07.03.Severfield - Full year trading update disappoints255Trading conditions have not improved as hoped for in the second half of the current financial year, which has resulted in a reduction in Severfield's expected outcome for FY25. This weakness is reflected...
► Artikel lesen
07.03.Patria Private Equity Trust - An attractive route to the PE mid-market262Patria Private Equity Trust (formerly known as abrdn Private Equity Opportunities Trust) allows investors to gain exposure to a gradually rebounding private equity (PE) market via a trust active in...
► Artikel lesen
07.03.Informa - FY25-28 plan for leveraging B2B platform277Informa used its FY24 results presentation to highlight its strategy for the next three years. This is centred on leveraging the One Informa platform, focused on B2B, through its market-leading brands...
► Artikel lesen